Gastroenterology
Volume 134, Issue 5 , Pages 1570-1595 , May 2008

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

  • Bernard Levin

      Affiliations

    • The University of Texas MD Anderson Cancer Center, Houston, Texas
    • ,
  • David A. Lieberman

      Affiliations

    • Division of Gastroenterology, Oregon Health and Science University, Portland Veterans Medical Center, Portland, Oregon
    • ,
  • Beth McFarland

      Affiliations

    • Mallinckrodt Institute of Radiology, St Luke's Hospital, Diagnostic Imaging Associates, Chesterfield, Missouri
    • ,
  • Kimberly S. Andrews

      Affiliations

    • Cancer Control Science Department, American Cancer Society, Atlanta, Georgia
    • ,
  • Durado Brooks

      Affiliations

    • Cancer Control Science Department, American Cancer Society, Atlanta, Georgia
    • ,
  • John Bond

      Affiliations

    • Gastroenterology Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
    • ,
  • Chiranjeev Dash

      Affiliations

    • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    • ,
  • Francis M. Giardiello

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Seth Glick

      Affiliations

    • University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • David Johnson

      Affiliations

    • Eastern Virginia Medical School, Norfolk, Virginia
    • ,
  • C. Daniel Johnson

      Affiliations

    • Radiology Department, Mayo Clinic, Scottsdale, Arizona
    • ,
  • Theodore R. Levin

      Affiliations

    • Gastroenterology Department, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California
    • ,
  • Perry J. Pickhardt

      Affiliations

    • Radiology Department, University of Wisconsin Hospital and Clinics, Madison, Wisconsin
    • ,
  • Douglas K. Rex

      Affiliations

    • Indiana University, Indianapolis, Indiana
    • ,
  • Robert A. Smith

      Affiliations

    • Cancer Control Science Department, American Cancer Society, Atlanta, Georgia
    • ,
  • Alan Thorson

      Affiliations

    • Section of Colon and Rectal Surgery, Creighton University School of Medicine, and University of Nebraska College of Medicine, Omaha, Nebraska
    • ,
  • Sidney J. Winawer

      Affiliations

    • Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • American Cancer Society Colorectal Cancer Advisory Group
    • ,
  • US Multi-Society Task Force
    • ,
  • American College of Radiology Colon Cancer Committee

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2004. In: Bethesda, MD: National Cancer Institute; 2007;
  3. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119–2152
  4. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–657
  5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet. 1996;348:1472–1477
  6. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet. 1996;348:1467–1471
  7. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607
  8. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–394
  9. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin. 2007;57:90–104
  10. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371–379
  11. Bond JH. Colon polyps and cancer. Endoscopy. 2003;35:27–35
  12. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642
  13. Winawer SJ. Natural history of colorectal cancer. Am J Med. 1999;106:3S–6S
  14. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555–560
  15. Eddy D. ACS report on the cancer-related health checkup. CA Cancer J Clin. 1980;30:193–240
  16. Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992;42:296–299
  17. Byers T, Levin B, Rothenberger D, et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997 (American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer). CA Cancer J Clin. 1997;47:154–160
  18. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers (Also: update 2001—testing for early lung cancer detection). CA Cancer J Clin. 2001;51:38–75
  19. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003;53:44–55
  20. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed.. Baltimore, MD: Williams & Wilkins; 1996;
  21. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129–131
  22. Glick SN. Comparison of colonoscopy and double-contrast barium enema. N Engl J Med. 2000;343:1728
  23. Heiken JP, Bree RL, Foley WD, et al. Colorectal cancer screening. American College of Radiology (ACR) Appropriateness Criteria. Reston, VA: American College of Radiology; 2006;
  24. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–560
  25. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006;130:1865–1871
  26. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi- Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56:143–159
  27. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41:23–29
  28. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422
  29. Schroy PC, Heeren TC. Patient perceptions of stool-based DNA testing for colorectal cancer screening. Am J Prev Med. 2005;28:208–214
  30. Tangka FK, Molinari NA, Chattopadhyay SK, Seeff LC. Market for colorectal cancer screening by endoscopy in the United States. Am J Prev Med. 2005;29:54–60
  31. Lafata JE, Divine G, Moon C, Williams LK. Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med. 2006;31:202–209
  32. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137:132–141
  33. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood (Minnesota Colon Cancer Control Study). N Engl J Med. 1993;328:1365–1371
  34. Wilson JMG, Junger G. Principles and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968;
  35. Smith RA. Screening fundamentals. J Natl Cancer Inst Monogr. 1997;22:15–19
  36. Shapiro SScreening for secondary prevention of disease, in Armenian HK, Shapiro S (eds).Epidemiology and Health Services.1831998194Oxford University PressNew York, NY 206.
  37. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal- cancer screening in an average-risk population. N Engl J Med. 2004;351:2704–2714
  38. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142:81–85
  39. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86–94
  40. Sox HC. Office-based testing for fecal occult blood: do only in case of emergency. Ann Intern Med. 2005;142:146–148
  41. Myers RE, Balshem AM, Wolf TA, et al. Adherence to continuous screening for colorectal neoplasia. Med Care. 1993;31:508–519
  42. Engelman KK, Ellerbeck EF, Ahluwalia JS, et al. Fecal occult blood test use by Kansas medicare beneficiaries. Prev Med. 2001;33:622–626
  43. Schattner A, Gilad A. Primary care physicians' awareness and implementation of screening guidelines for colorectal cancer. Prev Med. 2002;35:447–452
  44. American College of Radiology Imaging Network. ACRIN Protocol 6656 (Computerized Tomographic Colonography: Performance Evaluation in a Multicenter Setting). http://www.acrin.org/TabID/146/Default.aspx2007;Accessed July 1
  45. Young GP, St John DJ. Selecting an occult blood test for use as a screening tool for large bowel cancer. In:  Rozen P,  Reich CB,  Winawer SJ editor. Frontiers of Gastrointestinal Research (Advances in Large Bowel Cancer: Policy,Prevention, Research and Treatment). Basel, Switzerland: Karger; 1991;p. 135–156
  46. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper (American College of Physicians). Ann Intern Med. 1997;126:811–822
  47. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal- cancer screening. N Engl J Med. 1996;334:155–159
  48. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985;88:820–837
  49. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1462–1470
  50. Sinatra MA, Young GP, St John DJ, et al. A study of laboratory based faecal occult blood testing in Melbourne, Australia (The Faecal Occult Blood Testing Study Group). J Gastroenterol Hepatol. 1998;13:396–400
  51. Adams EC, Layman KM. Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci. 1974;4:343–349
  52. Newman L. Medicare coverage group assesses effectiveness of new technologies. J Natl Cancer Inst. 2001;93:805–806
  53. Caligiore P, Macrae FA, St John DJ, et al. Peroxidase levels in food: relevance to colorectal cancer screening. Am J Clin Nutr. 1982;35:1487–1489
  54. Gopalswamy N, Stelling HP, Markert RJ, et al. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med. 1994;3:1043–1048
  55. Greenberg PD, Bertario L, Gnauck R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol. 2000;95:1331–1338
  56. Wong BC, Wong WM, Cheung KL, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther. 2003;18:941–946
  57. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac- based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152–2159
  58. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–255
  59. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428
  60. Cole SR, Young GP, Esterman A, et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10:117–122
  61. Nakama H, Yamamoto M, Kamijo N, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46:228–231
  62. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102–105
  63. Whitney D, Skoletsky J, Moore K, et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn. 2004;6:386–395
  64. Olson J, Whitney DH, Durkee K, Shuber AP. DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. Diagn Mol Pathol. 2005;14:183–191
  65. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000;119:1219–1227
  66. Calistri D, Rengucci C, Bocchini R, et al. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol. 2003;1:377–383
  67. Tagore KS, Lawson MJ, Yucaitis JA, et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer. 2003;3:47–53
  68. Brand RE, Ross ME, Shuber AP. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Am J Gastroenterol. 2004;99:1338–1341
  69. Syngal S, Stoffel E, Chung D, et al. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006;106:277–283
  70. Itzkowitz SH, Jandorf L, Brand R, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007;5:111–117
  71. Schroy PC, Lal S, Glick JT, et al. Patient preferences for colorectal cancer screening: how does stool DNA testing fare?. Am J Manag Care. 2007;13:393–400
  72. Berger BM, Schroy PC, Rosenberg JL, et al. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin Colorectal Cancer. 2006;5:338–343
  73. Zauber AG, Lansdorp-Vogelaar I, Wilschut J, et al. In: Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer: Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. Rockville,MD: Agency for Health Care Quality and Research; 2007;p. 1–84
  74. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology. 2005;128:192–206
  75. Woolf SH. A smarter strategy? (Reflections on fecal DNA screening for colorectal cancer). N Engl J Med. 2004;351:2755–2758
  76. Kutzner N, Hoffmann I, Linke C, et al. Noninvasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett. 2005;229:33–41
  77. Levin TR, Farraye FA, Schoen RE, et al. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005;54:807–813
  78. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–1575
  79. Thiis-Evensen E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999;34:414–420
  80. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95:622–625
  81. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet. 2002;359:1291–1300
  82. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE. J Natl Cancer Inst. 2002;94:1763–1772
  83. Gondal G, Grotmol T, Hofstad B, et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand J Gastroenterol. 2003;38:635–642
  84. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst. 2005;97:989–997
  85. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174
  86. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer (Veterans Affairs Cooperative Study Group 380). N Engl J Med. 2000;343:162–168
  87. Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611–1617
  88. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068
  89. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–1872
  90. Cordice JW, Johnson H. Anatomic distribution of colonic cancers in middle-class black Americans. J Natl Med Assoc. 1991;83:730–732
  91. Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer. 1997;80:193–197
  92. Francois F, Park J, Bini EJ. Colon pathology detected after a positive screening flexible sigmoidoscopy: a prospective study in an ethnically diverse cohort. Am J Gastroenterol. 2006;101:823–830
  93. Theuer CP, Taylor TH, Brewster WR, et al. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg. 2001;67:1157–1161
  94. Atkin W, Rogers P, Cardwell C, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology. 2004;126:1247–1256
  95. Schoen RE, Pinsky PF, Weissfeld JL, et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA. 2003;290:41–48
  96. Doria-Rose VP, Newcomb PA, Levin TR. Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer. Gut. 2005;54:1273–1278
  97. Schoen RE, Weissfeld JL, Pinsky PF, Riley T. Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy. Gastroenterology. 2006;131:1683–1689
  98. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145:880–886
  99. Bini EJ, Unger JS, Rieber JM, et al. Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy. Gastrointest Endosc. 2000;52:218–222
  100. Zubarik R, Ganguly E, Benway D, et al. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy. Am J Gastroenterol. 2002;97:3056–3061
  101. Pinsky PF, Schoen RE, Weissfeld JL, et al. Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol. 2005;3:792–797
  102. Levin TR, Conell C, Shapiro JA, et al. Complications of screening flexible sigmoidoscopy. Gastroenterology. 2002;123:1786–1792
  103. Gross CP, Andersen MS, Krumholz HM, et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815–2822
  104. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? (Results from CDC's survey of endoscopic capacity). Gastroenterology. 2004;127:1670–1677
  105. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs?. Ann Intern Med. 1999;130:525–530
  106. Palitz AM, Selby JV, Grossman S, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract. 1997;11:5–12
  107. Rex DK, Imperiale TF, Latinovich DR, Bratcher LL. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol. 2002;97:1696–1700
  108. Takahashi Y, Tanaka H, Kinjo M, Sakumoto K. Sedation-free colonoscopy. Dis Colon Rectum. 2005;48:855–859
  109. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy (A case-control study of 32,702 veterans). Ann Intern Med. 1995;123:904–910
  110. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy (The National Polyp Study Workgroup). N Engl J Med. 1993;329:1977–1981
  111. Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–815
  112. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129:34–41
  113. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas (Phoenix Colon Cancer Prevention Physicians' Network). N Engl J Med. 2000;342:1156–1162
  114. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas (Polyp Prevention Trial Study Group). N Engl J Med. 2000;342:1149–1155
  115. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–218
  116. Ling BS, Moskowitz MA, Wachs D, et al. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001;16:822–830
  117. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? (A national survey of colorectal surveillance after polypectomy). Ann Intern Med. 2004;141:264–271
  118. Pabby A, Schoen RE, Weissfeld JL, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Tr ial. Gastrointest Endosc. 2005;61:385–391
  119. Farrar WD, Sawhney MS, Nelson DB, et al. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol. 2006;4:1259–1264
  120. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28
  121. Pickhardt PJ, Nugent PA, Mysliwiec PA, et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004;141:352–359
  122. Bressler B, Paszat LF, Vinden C, et al. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology. 2004;127:452–456
  123. Gatto NM, Frucht H, Sundararajan V, et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95:230–236
  124. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US Multi- Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002;97:1296–1308
  125. Faigel DO, Pike IM, Baron TH, et al. Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol. 2006;101:866–872
  126. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007;65:757–766
  127. Harewood GC, Lieberman DA. Colonoscopy practice patterns since introduction of Medicare coverage for average-r isk screening. Clin Gastroenterol Hepatol. 2004;2:72–77
  128. Levin TR. Colonoscopy capacity: Can we build it? (Will they come?). Gastroenterology. 2004;127:1841–1844
  129. Ladabaum U, Song K, Fendrick AM. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?. Clin Gastroenterol Hepatol. 2004;2:554–563
  130. Vijan S, Inadomi J, Hayward RA, et al. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther. 2004;20:507–515
  131. Boolchand V, Olds G, Singh J, et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145:654–659
  132. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27–43
  133. Glick SN, Ralls PW, Balfe DM, et al. Screening for colorectal cancer (American College of Radiology. ACR Appropriateness Criteria). Radiology. 2000;215(suppl):231–237
  134. Colorectal Cancer Screening Tests: Conditions for and Limitations on Coverage, 62 Federal Register 410.37 (1997).
  135. Glick S. Double-contrast barium enema for colorectal cancer screening: a review of the issues and a comparison with other screening alternatives. AJR Am J Roentgenol. 2000;174:1529–1537
  136. de Zwart IM, Griffioen G, Shaw MP, et al. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants. Clin Radiol. 2001;56:401–409
  137. Kelvin FM, Gardiner R, Vas W, Stevenson GW. Colorectal carcinoma missed on double contrast barium enema study: a problem in perception. AJR Am J Roentgenol. 1981;137:307–313
  138. Thorpe CD, Grayson DJ, Wingfield PB. Detection of carcinoma of the colon and rectum by air contrast enema. Surg Gynecol Obstet. 1981;152:307–309
  139. Fork FT, Lindström C, Ekelund G. Double contrast examination in carcinoma of the colon and rectum (A prospective clinical series). Acta Radiol Diagn (Stockh). 1983;24:177–188
  140. Johnson CD, Carlson HC, Taylor WF, Weiland LP. Barium enemas of carcinoma of the colon: sensitivity of double- and single-contrast studies. AJR Am J Roentgenol. 1983;140:1143–1149
  141. Reiertsen O, Bakka A, Tronnes S, Gauperaa T. Routine double contrast barium enema and fiberoptic colonoscopy in the diagnosis of colorectal carcinoma. Acta Chir Scand. 1988;154:53–55
  142. Thomas RD, Fairhurst JJ, Frost RA. Wessex regional radiology audit: barium enema in colorectal carcinoma. Clin Radiol. 1995;50:647–650
  143. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997;112:17–23
  144. Strøm E, Larsen JL. Colon cancer at barium enema examination and colonoscopy: a study from the county of Hordaland, Norway. Radiology. 1999;211:211–214
  145. Gillespie JS, Kelly BE. Double contrast barium enema and colorectal carcinoma: sensitivity and potential role in screening. Ulster Med J. 2001;70:15–18
  146. McDonald S, Lyall P, Israel L, et al. Why barium enemas fail to identify colorectal cancers. ANZ J Surg. 2001;71:631–633
  147. Connolly DJ, Traill ZC, Reid HS, et al. The double contrast barium enema: a retrospective single centre audit of the detection of colorectal carcinomas. Clin Radiol. 2002;57:29–32
  148. Leslie A, Virjee JP. Detection of colorectal carcinoma on double contrast barium enema when double reporting is routinely performed: an audit of current practice. Clin Radiol. 2002;57:184–187
  149. Tan KY, Seow-Choen F, Ng C, et al. Which colorectal cancers are missed by double contrast barium enema?. Tech Coloproctol. 2004;8:169–172
  150. Tawn DJ, Squire CJ, Mohammed MA, Adam EJ. National audit of the sensitivity of double-contrast barium enema for colorectal carcinoma, using control charts: For the Royal College of Radiologists Clinical Radiology Audit Sub-Committee. Clin Radiol. 2005;60:558–564
  151. Williams CB, Macrae FA, Bartram CI. A prospective study of diagnostic methods in adenoma follow-up. Endoscopy. 1982;14:74–78
  152. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy (National Polyp Study Work Group). N Engl J Med. 2000;342:1766–1772
  153. Zauber AG, Winawer S, Stewart ET. Author reply. N Engl J Med. 2000;343:1729–1730
  154. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant Radiologists 1992 to 1994. Clin Radiol. 1997;52:142–148
  155. American College of Radiology. Appropriateness Criteria for the Barium Enema. Reston, VA: American College of Radiology; 2004;
  156. El-Serag HB, Petersen L, Hampel H, et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006;166:2202–2208
  157. Ferrucci JT. Double-contrast barium enema: use in practice and implications for CT colonography. AJR Am J Roentgenol. 2006;187:170–173
  158. Robertson RH, Burkhardt JH, Powell MP, et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999–2001. Prev Med. 2006;42:460–462
  159. Zalis ME, Perumpillichira J, Del Frate C, Hahn PF. CT colonography: digital subtraction bowel cleansing with mucosal reconstruction initial observations. Radiology. 2003;226:911–917
  160. Iannaccone R, Laghi A, Catalano C, et al. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology. 2004;127:1300–1311
  161. Lefere P, Gryspeerdt S, Marrannes J, et al. CT colonography after fecal tagging with a reduced cathartic cleansing and a reduced volume of barium. AJR Am J Roentgenol. 2005;184:1836–1842
  162. Hara AK, Johnson CD, Reed JE, et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology. 1997;205:59–65
  163. Fenlon HM, Nunes DP, Schroy PC, et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999;341:1496–1503
  164. Yee J, Akerkar GA, Hung RK, et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology. 2001;219:685–692
  165. Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004;291:1713–1719
  166. Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005;365:305–311
  167. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191–2200
  168. Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology. 2005;237:893–904
  169. Mulhall BP, Veerappan GR, Jackson JL. Metaanalysis: computed tomographic colonography. Ann Intern Med. 2005;142:635–650
  170. Cash B, Kim C, Cullen P, et al. Accuracy of computed tomographic colonography for colorectal cancer screening in asymptomatic individuals. Gastroenterology. 2006;130:A46;[abstract] Abstract 278
  171. Graser A, Kolligs F, Kramer H, et al. Results from the “Munich Colorectal Cancer Prevention Tr ial”: comparison of low-dose 64-MDCT colonography and video colonoscopy in a screening population. European Radiology Supplements. 2006;26(suppl):C19–C27[abstract] Presented at: European Society of Gastrointestinal and Abdominal Radiology/Society of Gastrointestinal Radiologists; June 19–23, 2006
  172. Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357:1403–1412
  173. Knechtges PM, McFarland BG, Keysor KJ, et al. National and local trends in CT colonography reimbursement: past, present, and future. J Am Coll Radiol. 2007;4:776–799
  174. Pickhardt PJ, Taylor AJ, Kim DH, et al. Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology. 2006;241:417–425
  175. Fidler JL, Johnson CD, MacCarty RL, et al. Detection of flat lesions in the colon with CT colonography. Abdom Imaging. 2002;27:292–300
  176. Pickhardt PJ, Nugent PA, Choi JR, Schindler WR. Flat colorectal lesions in asymptomatic adults: implications for screening with CT virtual colonoscopy. AJR Am J Roentgenol. 2004;183:1343–1347
  177. Bond JH. Doubling time of flat and polypoid colorectal neoplasms: defining the adenomacarcinoma sequence. Am J Gastroenterol. 2000;95:1621–1623
  178. Zauber AG, O'Brien MJ, Winawer SJ. On finding flat adenomas: is the search worth the gain?. Gastroenterology. 2002;122:839–840
  179. Park SH, Lee SS, Choi EK, et al. Flat colorectal neoplasms: definition, importance, and visualization on CT colonography. AJR Am J Roentgenol. 2007;188:953–959
  180. Gupta S, Durkalski V, Cotton P, Rockey DC. Variation of agreement in polyp size measurement between computed tomographic colonography and pathology assessment: clinical implications. Clin Gastroenterol Hepatol. 2008;6:220–227
  181. Pickhardt PJ, Lee AD, McFarland EG, Taylor AJ. Linear polyp measurement at CT colonography: in vitro and in vivo comparison of two-dimensional and three-dimensional displays. Radiology. 2005;236:872–878
  182. Park SH, Choi EK, Lee SS, et al. Polyp measurement reliability, accuracy, and discrepancy: optical colonoscopy versus CT colonography with pig colonic specimens. Radiology. 2007;244:157–164
  183. Young BM, Fletcher JG, Paulsen SR, et al. Polyp measurement with CT colonography: multiple- reader, multiple-workstation comparison. AJR Am J Roentgenol. 2007;188:122–129
  184. Amis ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007;4:272–284
  185. Brenner DJ, Hall EJ. Computed tomography— an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284
  186. Ron E. Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res. 1998;150:S30–S41
  187. Health Physics Society. Radiation Risk in Perspective. Position Statement of the Health Physics Society. McLean, VA: Health Physics Society; 2004;http://www.hps.org/documents/risk_ps010- 1.pdfAccessed January 30, 2008
  188. Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern?. Gastroenterology. 2005;129:328–337
  189. Macari M, Bini EJ, Xue X, et al. Colorectal neoplasms: prospective comparison of thin-section low-dose multi-detector row CT colonography and conventional colonoscopy for detection. Radiology. 2002;224:383–392
  190. American College of Radiology. ACR Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. Reston,VA: American College of Radiology; 2006;
  191. Pickhardt PJ. Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults. Radiology. 2006;239:313–316
  192. Burling D, Halligan S, Slater A, et al. Potentially serious adverse events at CT colonography in symptomatic patients: national survey of the United Kingdom. Radiology. 2006;239:464–471
  193. Sosna J, Blachar A, Amitai M, et al. Colonic perforation at CT colonography: assessment of risk in a multicenter large cohor t. Radiology. 2006;239:457–463
  194. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology. 2000;215:353–357
  195. Gluecker TM, Johnson CD, Wilson LA, et al. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology. 2003;124:911–916
  196. Yee J, Kumar NN, Godara S, et al. Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology. 2005;236:519–526
  197. Pickhardt PJ, Taylor AJ. Extracolonic findings identified in asymptomatic adults at screening CT colonog raphy. AJR Am J Roentgenol. 2006;186:718–728
  198. Lieberman D. A call to action—measuring the quality of colonoscopy. N Engl J Med. 2006;355:2588–2589
  199. Zalis ME, Barish MA, Choi JR, et al. CT colonography reporting and data system: a consensus proposal. Radiology. 2005;236:3–9
  200. Kim DH, Pickhardt PJ, Hoff G, Kay CL. Computed tomographic colonography for colorectal screening. Endoscopy. 2007;39:545–549
  201. Kim DH, Pickhardt PJ, Taylor AJ. Characteristics of advanced adenomas detected at CT colonographic screening: implications for appropriate polyp size thresholds for polypectomy versus surveillance. AJR Am J Roentgenol. 2007;188:940–944
  202. Moravec M, Lieberman D, Holub J, et al. Rate of advanced pathologic features in 6–9mm polyps in patients referred for colonoscopy screening. Gastrointest Endosc. 2007;65:822
  203. Rex DK, Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol. 2006;101:1410–1413
  204. Rockey DC, Barish M, Brill JV, et al. Standards for gastroenterologists for performing and interpreting diagnostic computed tomographic colonography. Gastroenterology. 2007;133:1005–1024
  205. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96–104
  206. Song K, Fendrick AM, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology. 2004;126:1270–1279
  207. Wu GH, Wang YM, Yen AM, et al. Costeffectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer. 2006;6:136
  208. Pickhardt PJ, Hassan C, Laghi A, et al. Costeffectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer. 2007;109:2213–2221
  209. Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–523
  210. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 384 November 2007: colonoscopy and colorectal cancer screening and prevention. Obstet Gynecol. 2007;110:1199–1202

 ACS CRC Advisory Group Members: Bernard Levin, MD (Chair); Professor Emeritus, The University of Texas MD Anderson Cancer Center, Houston, TX; Tim Byers, MD, MPH (Vice Chair); Professor, Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO; Briggs W. Andrews, Esq; Senior Vice President; and General Counsel of Carilion Health System, Roanoke, VA; Elvan Daniels, MD; Associate Director for Community-Oriented Primary Care, Morehouse School of Medicine, Atlanta, GA; Lovell Jones, PhD; Professor of Gynecologic Oncology; and Director, Center of Excellence for Research on Minority Health, The University of Texas MD Anderson Cancer Center, Houston, TX; Gordon Klatt, MD; Medical Director, Cancer Programs, Mt. Rainier Surgical Association, Tacoma, WA; Theodore R. Levin, MD; Staff Physician, Gastroenterology Department, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, CA; Pamela McAllister, PhD; Founding Member and Research Advocate, Colorectal Cancer Coalition, Madison, WI; Beth McFarland, MD; Adjunct Professor, Mallinckrodt Institute of Radiology, St Luke's Hospital, Diagnostic Imaging Associates, Chesterfield, MO; Sigurd Normann, MD, PhD; Professor, Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL; Miquel Rodriguez-Bigas, MD; Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Alan Thorson, MD; Associate Professor of Surgery; and Program Director, Section of Colon and Rectal Surgery, Creighton University School of Medicine; and Clinical Associate Professor of Surgery, University of Nebraska College of Medicine, Omaha, NE; Richard Wender, MD; Chair; and Alumni Professor, Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA.

 ACS Staff and Consultants: Durado Brooks, MD, MPH; Director, Prostate and CRC, Cancer Control Science Department, American Cancer Society, Atlanta, GA; Robert A. Smith, PhD; Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA; Kimberly S. Andrews; Research Associate, Cancer Control Science Department, American Cancer Society, Atlanta, GA; Chiranjeev Dash, MBBS, MPH; Doctoral Candidate, Department of Epidemiology, Emory University, Rollins School of Public Health, Atlanta, GA.

 US Multi-Society Task Force Members: David A. Lieberman, MD; Chief, Division of Gastroenterology, Oregon Health and Science University, Portland Veterans Medical Center, Portland, OR; Francis M. Giardiello, MD; John G. Rangos Sr Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Theodore R. Levin, MD; Staff Physician, Gastroenterology Department, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, CA; Douglas K. Rex, MD; Professor of Medicine, Indiana University, Indianapolis, IN; Clyde Watkins, Jr, MD; Physician, Capstone Medical Group PC, Lithonia, GA; Sidney J. Winawer, MD; Attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY.

 American College of Radiology Colon Cancer Committee Members: Beth McFarland, MD; Adjunct Professor, Mallinckrodt Institute of Radiology, St Luke's Hospital, Diagnostic Imaging Associates, Chesterfield, MO; Seth Glick, MD; Clinical Professor of Radiology, University of Pennsylvania Health System, Philadelphia, PA; Perry Pickhardt, MD; Associate Professor, Radiology Department, University of Wisconsin Hospital and Clinics, Madison, WI.

 This article is being published jointly in 2008 in CA: A Cancer Journal for Clinicians (online: March 5, 2008; print: May/June 2008), Gastroenterology (online: March 31, 2008; print: May, 2008), and Radiology (June, 2008) by the American Cancer Society, the American Gastroenterological Association (AGA) Institute, and the Radiological Society of North America.

 Authors J. Bond, D. Johnson and C.D. Johnson were not included as authors in the CA online version of this paper published on March 5. The authors were subsequently added and will appear in the May/June 2008 printed version of CA along with an erratum. Also, The American Gasteroenterological Association (AGA) Institute was misidentified as the American Gasteroenterology Association in the CA online version of this paper. This will also be corrected in a CA erratum.

 Workgroup members were asked to disclose relationships, including potential financial conflicts of interest. The following was disclosed: D. Lieberman served on the scientific advisory board for Exact Sciences, ending September 30, 2007. B. McFarland receives honoraria for serving on the medical advisory boards for Vital Images and Medicsight. P. Pickhardt serves as a paid consultant to Covidien, Viatronix, Fleet, Medicsight, and Philips. D. Rex receives an honorarium for serving as a speaker and research support for serving as an investigator for Olympus; serves on the scientific advisory board and receives research support for serving as an investigator for Given Imaging; and serves on the scientific advisory boards for Avantis, NeoGuide, G.I. View, and American BioOptics. M. Rodriguez–Bigas receives an honorarium for serving on the speaker's bureau for Genzyme. R. Wender serves on the scientific advisory boards for Epigenomics, GeneNews, and G.I. View, but receives no personal income for doing so.

 The following article contains new recommendations for colorectal cancer screening, the first set we have published since 2003 (Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003;124:544–560.) The current recommendations have emerged through the participation of multiple national societies, taking into consideration newly emerging technologies. Please note the US Multi-Society Task Force (USMTF) represents the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy, and the American College of Gastroenterology. Commissioned originally by the American Cancer Society, this compendium will be published concurrently in CA: A Cancer Journal for Clinicians and reprinted in the June issue of Radiology.

PII: S0016-5085(08)00232-1

doi: 10.1053/j.gastro.2008.02.002

Gastroenterology
Volume 134, Issue 5 , Pages 1570-1595 , May 2008

Article Tools